Christine Burlein
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)United States Military Academy(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, HIV Research and Treatment, Biochemical and Molecular Research, Click Chemistry and Applications
Most-Cited Works
- → MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants(2012)254 cited
- → Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor(2012)201 cited
- → Structure−Activity Relationship of Purine Ribonucleosides for Inhibition of Hepatitis C Virus RNA-Dependent RNA Polymerase(2004)187 cited
- → Structure−Activity Relationship of Heterobase-Modified 2‘-C-Methyl Ribonucleosides as Inhibitors of Hepatitis C Virus RNA Replication(2004)185 cited
- → Design, Synthesis, and X-ray Crystallographic Analysis of a Novel Class of HIV-1 Protease Inhibitors(2011)76 cited
- → Structural characterization of nonactive site, TrkA-selective kinase inhibitors(2016)48 cited